George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
At over £10 a share I would come to the party with a fancy new hair unit, I could even buy some new clothes from Tesco’s
Yep, I could even treat the wife to another pair of shoes, apparently 30 pairs are not enough…
that would blow your £2.36 party out of the water OB. Come on man, think bigger haha.
Imagine a deal like this. 625 million upfront payment. Goes to show our market cap of 11 million is very low and we have 2 phase 2 proven drugs and a very promising preclinical drug. Although it is completely different big money paid for some early stage drugs and nothing beats the need for a cure for endometriosis.
It is not wonder why PYC signed a 6 per cent deal with Val. 18p is a steal at the moment.
https://www.evaluate.com/vantage/articles/news/snippets/glaxo-pays-handsomely-join-tigit-chase
Did another little top up,will be marked as a sell as well under mid price.
Thanks Iceman for the detail. So Sept should be a cut off point for a Cash Deal Injection. Otherwise keep spending the Cash untill It runs out. Can you Imagine Raising Cash with very little In the Kitty. Doe's that sound familiar?. IMO.
TDK no worries:)
Ah that reminds me…A1 we were playing guess who, and I think you got called in for your tea
Are you allowed back out to play?
My comment was a total shambles sorry OB. Written like A1 had proof read it.
Mine gladly. If we had a ceo that said that I would be worried.
Common Suzie do not disappoint us .
Hi TDK
Was the comment “won’t be long” your comment or Suzy’s ?
OB
I have asked for the board to explain in the next Q&A how they plan to sell Valirx to new II. As i see it at present the SP is being held up (sort of) by a few long term holders and there isnt much new blood about. Suzy as usual replied promptly. SP is doing well considering how little positive news we have had this year.
Wont be long.
From RNS dated 27 April.
-- Cash balance at 31 December 2020 GBP1,846,901; Cash balance at 31 March 2021 GBP1,502,885, demonstrating quarterly cash requirement of approximately GBP350,000.
1 April 2021 to 30 June 2021 = £350,000 BALANCE = £1,502,885 -350,000 = £1,152,885
1 July 2021 to 30 Sep 2021 = £350,000 BALANCE = £1,152,885 -350,000 = £802,885
1 Oct 2021 to 31 Dec 2021 =£350,000 BALANCE = £802,885 -350,000 = £452,885
1 Jan 2022 to 31 Mar 2020 = 350,000 BALANCE = £452,885 -350,000 = £102,885
1st April 2022 Balance = £102,885
We have funds for another +10 months! Funding should not be an issue!
We should conclude at least one of the two deals soon. VAL201 holds the biggest potential but VAL301 could come sooner!
I see a lot of frustration here. PYC should have completed all the work on VAL201 few weeks or months back so maybe giving us an update on this might reassure investors.
How about publishing a descriptive peer-review article on VAL201 results? This was mentioned in the live Q&A two months ago.